Company performance
Current Price
as of Jan 23, 2025$16.41
P/E Ratio
3.25
Market Cap
$4.23B
Description
Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.
Metrics
Overview
- HQJersey City, NJ
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerOGN
- Price$16.41+3.40%
Trading Information
- Market cap$4.23B
- Float99.78%
- Average Daily Volume (1m)2,676,617
- Average Daily Volume (3m)3,481,249
- EPS$5.07
Company
- Revenue$6.41B
- Rev growth (1yr)4.15%
- Net income$359.00M
- Gross margin58.34%
- EBITDA margin29.01%
- EBITDA$459.00M
- EV$12.96B
- EV/Revenue2.02
- P/E3.25
- P/S0.67
- P/B8.57
Documents
SEC Filings
Earnings Calls
Factset Street Account